ResMed Non-GAAP EPS of $2.81 beats by $0.09, revenue of $1.4B in-line
Source: SeekingAlpha
2026-01-29 16:09:12 ET
More on ResMed
- 44th Annual J.P. Morgan Healthcare Conference
- ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ResMed: Safe Bet For A Recession Environment
- ResMed Q2 2026 Earnings Preview
- Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026
Read the full article on Seeking Alpha
For further details see:
ResMed Non-GAAP EPS of $2.81 beats by $0.09, revenue of $1.4B in-line
ResMed Inc.
NASDAQ: RMD
RMD Trading
0.77% G/L:
$230.175 Last:
348,126 Volume:
$226.83 Open:
RMD Latest News
March 03, 2026 03:00:00 am
Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
February 24, 2026 09:00:00 am
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
January 29, 2026 04:05:00 pm
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
RMD Stock Data
$39,533,476,071
144,731,491
0.09%
478
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
